Literature DB >> 6162516

The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus.

J Dodd, J S Kelly.   

Abstract

The presence of cholecystokinin octapeptide (CCK-8) immunoreactivity in the vicinity of the pyramidal neurones of the mammalian hippocampus has allowed us to investigate the central postsynaptic actions of CCK-8 and a number of related peptides, at a site thought to be innervated by a peptidergic pathway. Intracellular records from pyramidal cells of the CA1 region of the hippocampal slice preparation were used to determine changes in excitability and associated changes in membrane potential and resistance evoked by the pressure application of peptides into the cell body layer, from an independently mounted multibarrelled micropipette. The tetra- and octa-peptide C-terminal fragments of cholecystokinin evoked abrupt and rapidly reversible depolarizations which were accompanied by marked increases in excitability and a decrease in membrane input resistance. A comparison was made of the actions of these peptides with those of glutamate, released by iontophoresis from an adjacent barrel of the same multibarrelled pipette. The rate of onset of the cholecystokinin-evoked response was similar to that of the response evoked by glutamate. C-terminal fragments of gastrin (G-13 and G-14) and bombesin were also found to be excitatory to pyramidal neurones in the CA1 region. However, the nonsulphated form of CCK-8 was inactive, as was substance P, a peptide not present in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6162516     DOI: 10.1016/0006-8993(81)90344-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  28 in total

1.  CCK-immunoreactive terminals form different types of synapses in the rat and monkey hippocampus.

Authors:  C Leranth; M Frotscher; P Rakic
Journal:  Histochemistry       Date:  1988

2.  Tachykinins and bombesin excite non-pyramidal neurones in rat hippocampus.

Authors:  J J Dreifuss; M Raggenbass
Journal:  J Physiol       Date:  1986-10       Impact factor: 5.182

3.  Non-pyramidal neurons in the guinea pig hippocampus. A combined Golgi-electron microscope study.

Authors:  M Schlander; M Frotscher
Journal:  Anat Embryol (Berl)       Date:  1986

Review 4.  Cholecystokinin receptors.

Authors:  P Boden; M D Hall; J Hughes
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

5.  Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons.

Authors:  K K Miller; A Hoffer; K R Svoboda; C R Lupica
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

6.  Ontogeny of cholecystokinin-8 and glutamic acid decarboxylase in cerebral neocortex of macaque monkey.

Authors:  M Hayashi; A Yamashita; K Shimizu; K Oshima
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

7.  Cholecystokinin action on layer 6b neurons in somatosensory cortex.

Authors:  Leeyup Chung; Scott D Moore; Charles L Cox
Journal:  Brain Res       Date:  2009-06-02       Impact factor: 3.252

8.  A bicuculline-resistant inhibitory post-synaptic potential in rat hippocampal pyramidal cells in vitro.

Authors:  N R Newberry; R A Nicoll
Journal:  J Physiol       Date:  1984-03       Impact factor: 5.182

9.  A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain.

Authors:  C Rose; A Camus; J C Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy.

Authors:  J Shlik; E Vasar; J Bradwejn
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.